Technologies Available for Licensing
SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS
This disclosure relates to materials and methods for inhibiting Botulinum neurotoxin, and more particularly to materials and methods for inhibiting the zinc endopeptidase of Botulinum neurotoxin serotypes A, D and/or E (BoNTA, BoNTD and/or BoNTE).
More Detail:Visit USPTO.GOV
Inventor(s):SCHMIDT, J.; MILLARD, C.; PANG, Y.; PARK, J.; TANG, J.